The head and neck oncology program has 26 members from three schools and nine Departments supported by more than $1.5 million annual direct costs. This program which was a developing program at the last submission has now matured into a full program. The program has now co-directors, Carol Bradford, M.D., and Thomas Carey, Ph.D. It conducts weekly multi-disciplinary head and neck tumor boards, monthly program meetings, and a annual day-long retreat at an off-site location to discuss clinical protocols and basic sciences advances as well as future directions. A head and neck oncology research consortium formed in 1999 generated the team of scientists and physicians which constitutes our basic and translational research program. Under the new leadership, new initiatives and collaborations have developed, and the program has grown to have significant NIH funding. Program members plan to submit a SPORE application in the year 2001. At the present time, the program has nine active investigator-initiative clinical protocols. The highly focused clinical and research themes of the program pertain to organ-sparing modalities to treat head and neck cancer and molecular markers to predict response to treatment. Former program director and current program member, Gregory Wolf, M.D., Chair of the Department of Otolaryngology, pioneered organ preservation treatment in advanced cancer of the larynx.. The active clinical protocols expand upon this theme with concomitant chemotherapy and radiation approaches to the larynx and other sites within the head and neck. Interprogrammatic collaborations with the Experimental Therapeutics Program has led to active clinical protocols and basic science investigations in radiosensitization with Gemcitabine. Collaborations with the Socio- Behavioral Program has led to funded research programs investigating quality of life. These programs involve patients with head and neck tumors who are receiving parotid-sparing comprehensive irradiation and others in whom smoking, alcohol and depression intervention is investigated. Collaborations with the Dental School have led to a Research Career Award for a promising young investigator, Nisha D'Silva, D.D.S., Ph.D. The highly interactive program has strong intra- and inter-programmatic collaborations with more than 40 joint publications and nine new collaborative grant applications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046592-15
Application #
6597036
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-06-01
Project End
2003-05-31
Budget Start
Budget End
Support Year
15
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Hoban, Connor W; Beesley, Lauren J; Bellile, Emily L et al. (2018) Individualized outcome prognostication for patients with laryngeal cancer. Cancer 124:706-716
Maust, Joel D; Frankowski-McGregor, Christy L; Bankhead 3rd, Armand et al. (2018) Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers. Mol Cancer Ther 17:2495-2506
Arthur, Anna E; Goss, Amy M; Demark-Wahnefried, Wendy et al. (2018) Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: results from a prospective cohort study. Int J Cancer 143:1105-1113
Valenciaga, Anisley; Saji, Motoyasu; Yu, Lianbo et al. (2018) Transcriptional targeting of oncogene addiction in medullary thyroid cancer. JCI Insight 3:
Akkina, Sarah R; Kim, Roderick Y; Stucken, Chaz L et al. (2018) Is There a Difference in Staging and Treatment of Head and Neck Squamous Cell Tumors Between Tertiary Care and Community-Based Institutions? Laryngoscope Investig Otolaryngol 3:290-295
Anwar, Talha; Arellano-Garcia, Caroline; Ropa, James et al. (2018) p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis. Nat Commun 9:2801
Giraldez, Maria D; Spengler, Ryan M; Etheridge, Alton et al. (2018) Comprehensive multi-center assessment of small RNA-seq methods for quantitative miRNA profiling. Nat Biotechnol 36:746-757
Hartlerode, Andrea J; Regal, Joshua A; Ferguson, David O (2018) Reversible mislocalization of a disease-associated MRE11 splice variant product. Sci Rep 8:10121
Fritsche, Lars G; Gruber, Stephen B; Wu, Zhenke et al. (2018) Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative. Am J Hum Genet 102:1048-1061
Haley, Henry R; Shen, Nathan; Qyli, Tonela et al. (2018) Enhanced Bone Metastases in Skeletally Immature Mice. Tomography 4:84-93

Showing the most recent 10 out of 1493 publications